About
Schleifer earned a bachelor's degree from Cornell University and an M.D. and Ph.D. in pharmacology from the University of Virginia. He is a licensed physician certified in neurology and trained in neurology at New York Hospital before founding Regeneron. He chaired the board from 1990 to 1994 and has been co-chair since 2023. Whoo also has pages for other biopharma chief executives: David Ricks of Eli Lilly, Robert Bradway of Amgen and Chris Boerner of Bristol Myers Squibb.
Whoo compiled this page from public sources: Wikipedia, Regeneron 2026 proxy statement (SEC), Regeneron Form 8-K, 24 September 2026 (SEC). It is not affiliated with or endorsed by Leonard Schleifer. Are you Leonard Schleifer? Claim this page, or write to [email protected] to correct or remove it. Last updated: 2026-11-17.
Want a page like this? Create yours from your résumé.
Experience
Co-founder, President and Chief Executive Officer — Regeneron Pharmaceuticals
1988 – Present | Tarrytown, New York
- Board co-chair since 2023; chair of the board from 1990 to 1994
- Trained in neurology before founding Regeneron